Nuvilex, Inc. to Host a Fiscal Year 2010 Second Quarter Financial Results Call on December 22
CHERRY HILL, N.J.-- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today that it will hold a fiscal year 2010 second quarter financial results conference call on Tuesday, December 22, 2009 at 10:00AM ET. The conference call may be accessed in the United States by dialing 1 (866) 212 0875. For access to the call from outside of the United States dial 1 (972) 964 0031. The access code for the call is 1666516 followed by the # key. There will be a question and answer period after prepared remarks.
About Nuvilex, Inc.
Nuvilex, Inc. is an emerging healthcare consumer products company. The Company's lead products include: Cinnergen(TM), which promotes a healthy glucose metabolism; Cinnechol(TM), designed to help maintain normal cholesterol levels and support normal cardiovascular function; and Infinitink(R), a permanent yet more easily removable tattoo ink. The Company's complete portfolio spans aesthetics, dermatology, environmental and nutraceutical products, all of which are designed to directly or indirectly improve human health. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., the developer of Infinitink(R). In conjunction with the merger, the Company changed its name to Nuvilex, Inc. from eFoodSafety.com. Please visit
http://www.nuvilex.com/ for additional information on the Company.
Safe Harbor Statement
Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
Nuvilex Inc. Investor Relations Contacts:
Blair Barnes
Senior Vice President and Chief Financial Officer
856-433-6088
bbarnes@nuvilex.com
bbarnes@nuvilex.com
Press Contact for Nuvilex Inc.:
Arcand & Madison
Pat Arcand
617-576-7777
pat@am-pr.com
|
